Fig. 3From: A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasisProportion of patients achieving PASI 75 at week 24. ACT, acitretin; ETN, etanercept; PASI, Psoriasis Area Severity IndexBack to article page